Clinical Trials in San Antonio

Showing 9481-9500 of 11,125 trials

Drug Interaction Study With Rosuvastatin

NCT02101125

The purpose of this study is to evaluate the effect of concomitant administration of BMS-986020 on the single dose Pharmacokinetics (PK) of Rosuvastatin in healthy subjects.

Immunosuppression For Disease

Bristol-Myers Squibb26 participantsStarted Mar 2014

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

NCT01159600

The objective of the current study is to investigate the efficacy, safety and tolerability of two doses of BI 10773 compared to placebo given for 24 weeks as add-on therapy to metformin or metformin plus sulfonylurea in patients with Typ 2 Diabetes Mellitus with insufficient glycaemic control.

Diabetes Mellitus, Type 2

Boehringer Ingelheim1,504 participantsStarted Jul 2010

Birmingham, Alabama, United States • Tempe, Arizona, United States • Huntington Park, California, United States +145 more locations

Drug Interaction Study With Rosuvastatin

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Find Trials by Condition in San Antonio

Dapagliflozin DPPIV Inhibitor add-on Study

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

12 / 48 Week Pivotal PFT vs PBO in COPD I

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

Safety of Urate Elevation in Parkinson's Disease

AST-120 Used to Treat Mild Hepatic Encephalopathy

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Patient Registry Study of Berinert® in Normal Clinical Practice

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia